| __timestamp | Ionis Pharmaceuticals, Inc. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 241751000 | 31354781 |
| Thursday, January 1, 2015 | 322292000 | 43445817 |
| Friday, January 1, 2016 | 344320000 | 66489820 |
| Sunday, January 1, 2017 | 374644000 | 96886134 |
| Monday, January 1, 2018 | 414604000 | 153793000 |
| Tuesday, January 1, 2019 | 466000000 | 148369000 |
| Wednesday, January 1, 2020 | 535000000 | 151934000 |
| Friday, January 1, 2021 | 643000000 | 198532000 |
| Saturday, January 1, 2022 | 833000000 | 112128000 |
| Sunday, January 1, 2023 | 899625000 | 76192000 |
| Monday, January 1, 2024 | 901530000 |
In the ever-evolving landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Ionis Pharmaceuticals and TG Therapeutics have demonstrated contrasting trajectories in their R&D investments. From 2014 to 2023, Ionis Pharmaceuticals consistently increased its R&D expenses, peaking in 2023 with a staggering 272% increase from its 2014 spending. In contrast, TG Therapeutics showed a more volatile pattern, with a notable peak in 2021, where their R&D spending was approximately 533% higher than in 2014, before experiencing a decline in subsequent years. This divergence highlights Ionis's steady commitment to innovation, while TG Therapeutics appears to be navigating a more fluctuating path. As the biotech industry continues to grow, these spending patterns may offer insights into each company's strategic priorities and future potential.
R&D Insights: How Johnson & Johnson and Ionis Pharmaceuticals, Inc. Allocate Funds
R&D Insights: How Pfizer Inc. and TG Therapeutics, Inc. Allocate Funds
R&D Insights: How Bristol-Myers Squibb Company and TG Therapeutics, Inc. Allocate Funds
R&D Spending Showdown: Gilead Sciences, Inc. vs TG Therapeutics, Inc.
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs Ionis Pharmaceuticals, Inc.
Research and Development Investment: Biogen Inc. vs Ionis Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Ionis Pharmaceuticals, Inc. vs ADMA Biologics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Research and Development: Comparing Key Metrics for Ionis Pharmaceuticals, Inc. and MannKind Corporation
Comparing Innovation Spending: Ionis Pharmaceuticals, Inc. and Dynavax Technologies Corporation
Research and Development: Comparing Key Metrics for TG Therapeutics, Inc. and ADMA Biologics, Inc.
TG Therapeutics, Inc. or Galapagos NV: Who Invests More in Innovation?